{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:24:35Z","timestamp":1772558675253,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.clbc.2017.10.016","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T01:45:58Z","timestamp":1510710358000},"page":"e15-e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History"],"prefix":"10.1016","volume":"18","author":[{"given":"Giovanni","family":"Grandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1854-6701","authenticated-orcid":false,"given":"Angela","family":"Toss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Cagnacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Marcheselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Pavesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Cascinu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cortesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2017.10.016_bib2","first-page":"271","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2017.10.016_bib3","first-page":"65","article-title":"A\u00a0prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States)","volume":"8","author":"Hankinson","year":"1997","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clbc.2017.10.016_bib4","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2017.10.016_bib5","first-page":"1375","article-title":"Use of oral contraceptives and breast cancer risk: the Norwegian-Swedish Women's Lifestyle and Health Cohort study","volume":"11","author":"Kumle","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2017.10.016_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer: findings in a large cohort study, 1968-2004","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2017.10.016_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2017.10.016_bib8","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2017.10.016_bib9","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4065\/81.10.1290","article-title":"Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis","volume":"81","author":"Kahlenborn","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clbc.2017.10.016_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2407-6-210","article-title":"Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience","volume":"6","author":"Cortesi","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2017.10.016_bib11","doi-asserted-by":"crossref","first-page":"341723","DOI":"10.1155\/2015\/341723","article-title":"Hereditary ovarian cancer: not only BRCA 1 and 2 genes","volume":"2015","author":"Toss","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clbc.2017.10.016_bib12","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1200\/JCO.2007.11.1179","article-title":"Oral contraceptives and breast cancer risk in the international BRCA1\/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group","volume":"25","author":"Brohet","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2017.10.016_bib13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/humupd\/dmq022","article-title":"Hormonal contraception and risk of cancer","volume":"16","author":"Cibula","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.clbc.2017.10.016_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.contraception.2009.04.010","article-title":"Oral contraceptives and family history of breast cancer","volume":"80","author":"Gaffield","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.clbc.2017.10.016_bib15","first-page":"540","article-title":"Clinical inquiry: do oral contraceptives put women with a family history of breast cancer at increased risk?","volume":"63","author":"Freund","year":"2014","journal-title":"J\u00a0Fam Pract"},{"key":"10.1016\/j.clbc.2017.10.016_bib16","series-title":"Medical Eligibility Criteria for Contraceptive Use","year":"2015"},{"key":"10.1016\/j.clbc.2017.10.016_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/annonc\/mdt422","article-title":"A\u00a0rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1\/2-positive Italian women","volume":"25","author":"Cortesi","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2017.10.016_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/A:1006192230332","article-title":"Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal","volume":"55","author":"Federico","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.10.016_bib19","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A\u00a0breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.clbc.2017.10.016_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1214\/aos\/1176344247","article-title":"Nonparametric inference for a family of counting processes","volume":"6","author":"Aalen","year":"1978","journal-title":"Ann Stat"},{"key":"10.1016\/j.clbc.2017.10.016_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J\u00a0R Stat Soc Series B"},{"key":"10.1016\/j.clbc.2017.10.016_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1025728524310","article-title":"Oral contraceptives and the risk of ductal breast carcinoma in situ","volume":"81","author":"Claus","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.10.016_bib23","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","article-title":"Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2017.10.016_bib24","first-page":"1059","article-title":"Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study","volume":"16","author":"Silvera","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clbc.2017.10.016_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/ije\/19.2.240","article-title":"Oral contraceptives and breast cancer risk: a case-control study","volume":"19","author":"Harris","year":"1990","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clbc.2017.10.016_bib26","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/1097-0142(19830601)51:11<2147::AID-CNCR2820511133>3.0.CO;2-X","article-title":"Family history, oral contraceptive usage, and breast cancer","volume":"51","author":"Black","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2017.10.016_bib27","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1001\/jama.284.14.1791","article-title":"Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer","volume":"284","author":"Grabrick","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2017.10.016_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/oxfordjournals.aje.a008654","article-title":"Case-control study of oral contraceptive use and risk of breast cancer","volume":"143","author":"Rosenberg","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clbc.2017.10.016_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425255.2013.844229","article-title":"Pharmacokinetic evaluation of desogestrel as a female contraceptive","volume":"10","author":"Grandi","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clbc.2017.10.016_bib30","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.fertnstert.2009.10.016","article-title":"Comparison of effects of 3 mg drospirenone plus 20 \u03bcg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome","volume":"94","author":"Fruzzetti","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clbc.2017.10.016_bib31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/bjc.1993.175","article-title":"Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism","volume":"67","author":"Catherino","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2017.10.016_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0960-0760(92)90257-J","article-title":"Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditions","volume":"42","author":"van der Burg","year":"1992","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clbc.2017.10.016_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10549-016-3901-1","article-title":"A\u00a0novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women","volume":"158","author":"Secreto","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.10.016_bib34","doi-asserted-by":"crossref","first-page":"e78016","DOI":"10.1371\/journal.pone.0078016","article-title":"Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France","volume":"8","author":"Cordina-Duverger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2017.10.016_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsbmb.2005.02.014","article-title":"Progestins and progesterone in hormone replacement therapy and the risk of breast cancer","volume":"96","author":"Campagnoli","year":"2005","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clbc.2017.10.016_bib36","series-title":"Modern Epidemiology","author":"Rothman","year":"1998"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917304883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917304883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:16:29Z","timestamp":1761513389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820917304883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1526820917304883"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2017.10.016","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2017.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}